PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company offers clinical development and laboratory services to the pharmaceutical, biotechnology, and medical device and government organizations, as well as other industry participants. It operates in two segments, Clinical Development Services and Laboratory Services. The Clinical Development Services segment provides product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The Laboratory Services segment offers bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. The company operates in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.
Industry, Sector and Symbol
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone910-251-0081
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees23,000
Next Earnings Date3/4/2020 (Confirmed)
OptionableNot Optionable
PPD (NASDAQ:PPD) Frequently Asked Questions
What is PPD's stock symbol?
PPD trades on the NASDAQ under the ticker symbol "PPD."
When is PPD's next earnings date?
How can I listen to PPD's earnings call?
PPD will be holding an earnings conference call on Wednesday, March 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
Has PPD been receiving favorable news coverage?
News stories about PPD stock have been trending negative on Thursday, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. PPD earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for PPD.
Who are some of PPD's key competitors?
Some companies that are related to PPD include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), Icon (ICLR), Charles River Laboratories Intl. (CRL), Syneos Health (SYNH), PRA Health Sciences (PRAH), Exelixis (EXEL), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Intrexon (XON), Sorrento Therapeutics (SRNE), STARPHARMA HOLD/S (SPHRY) and Anavex Life Sciences (AVXL).
What other stocks do shareholders of PPD own?
Who are PPD's key executives?
PPD's management team includes the folowing people:
- Mr. David S. Simmons, Chairman & CEO (Age 55)
- Mr. Christopher G. Scully, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 49)
- Mr. William J. Sharbaugh, Chief Operating Officer (Age 57)
- Mr. Glen Donovan, Chief Accounting Officer (Age 46)
- Mr. B. Judd Hartman, Exec. VP, Gen. Counsel & Chief Admin. Officer (Age 56)
When did PPD IPO?
(PPD) raised $1.5 billion in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 60,000,000 shares at $24.00-$27.00 per share. Barclays, J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird and William Blair served as the underwriters for the IPO and BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird, William Blair and Drexel Hamilton were co-managers.
When does PPD's quiet period expire?
PPD's quiet period expires on Tuesday, March 17th. PPD had issued 60,000,000 shares in its initial public offering on February 6th. The total size of the offering was $1,620,000,000 based on an initial share price of $27.00. During PPD's quiet period, insiders and underwriters involved in the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
How do I buy shares of PPD?
Shares of PPD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is PPD's stock price today?
One share of PPD stock can currently be purchased for approximately $28.81.
How big of a company is PPD?
What is PPD's official website?
How can I contact PPD?
PPD's mailing address is 929 NORTH FRONT STREET, WILMINGTON NC, 28401. The company can be reached via phone at 910-251-0081.
MarketBeat Community Rating for PPD (NASDAQ PPD)
MarketBeat's community ratings are surveys of what our community members think about PPD and other stocks. Vote "Outperform" if you believe PPD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PPD will underperform the S&P 500 over the long term. You may vote once every thirty days.
